Correction of glycogen storage disease Ia in a murine model using a non-primate lentiviral vector

被引：0
|
作者：
Condiotti, Reba [1 ]
Grinshpun, Albert [1 ]
Peretz, Sima [2 ]
Chou, Janice [3 ]
Galun, Eithan [1 ]
机构：
[1] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel
[2] Harlan Biotech Israel Ltd, SPF Anim Facilities, Rehovot, Israel
[3] NIH, NICHHD, Heritable Disorders Branch, Bethesda, MD 20892 USA
来源：
HUMAN GENE THERAPY | 2007年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1072 / 1073
页数：2
相关论文
共 50 条
  • [1] Non-primate lentiviral vector administration in the TMJ
    Kyrkanides, S
    Kambylafkas, P
    Miller, JH
    Tallents, RH
    JOURNAL OF DENTAL RESEARCH, 2004, 83 (01) : 65 - 70
  • [2] Stable gene transter to the nervous system using a non-primate lentiviral vector
    Mitrophanous, KA
    Yoon, S
    Rohll, JB
    Patil, D
    Wilkes, FJ
    Kim, VN
    Kingsman, SM
    Kingsman, AJ
    Mazarakis, ND
    GENE THERAPY, 1999, 6 (11) : 1808 - 1818
  • [3] Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction
    Shai, E
    Palmon, A
    Panet, A
    Marmary, Y
    Sherman, Y
    Curran, MA
    Galun, E
    Condiotti, R
    MOLECULAR THERAPY, 2005, 12 (01) : 137 - 143
  • [4] Stable gene transfer to the nervous system using a non-primate lentiviral vector
    K A Mitrophanous
    S Yoon
    J B Rohll
    D Patil
    F J Wilkes
    V N Kim
    S M Kingsman
    A J Kingsman
    N D Mazarakis
    Gene Therapy, 1999, 6 : 1808 - 1818
  • [5] Prolonged liver-specific transgene expression by a non-primate lentiviral vector
    Condiotti, R
    Curran, MA
    Nolan, GP
    Giladi, H
    Ketzinel-Gilad, M
    Gross, E
    Galun, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (03) : 998 - 1006
  • [6] Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice
    Themis, M
    Waddington, SN
    Schmidt, M
    von Kalle, C
    Wang, YH
    Al-Allaf, F
    Gregory, L
    Nivsarkar, M
    Themis, M
    Holder, M
    Buckley, SMK
    Dighe, N
    Ruthe, A
    Mistry, A
    Bigger, B
    Thrasher, A
    Coutelle, C
    TOXICOLOGY, 2006, 219 (1-3) : 233 - 233
  • [7] AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia
    Koeberl, Dwight D.
    Pinto, Carlos
    Sun, Baodong
    Li, Songtao
    Kozink, Daniel M.
    Benjamin, Daniel K., Jr.
    Demaster, Amanda K.
    Kruse, Meghan A.
    Vaughn, Valerie
    Hillman, Steven
    Bird, Andrew
    Jackson, Mark
    Brown, Talmage
    Kishnani, Priya S.
    Chen, Yuan-Tsong
    MOLECULAR THERAPY, 2008, 16 (04) : 665 - 672
  • [8] Time kinetics of transgene expression in the liver following transduction of neonatal mice with a non-primate lentiviral vector
    Condiotti, Reba
    Simerzin, Alina
    Themis, Michael
    Waddington, Simon
    Galun, Eithan
    HUMAN GENE THERAPY, 2008, 19 (10) : 1122 - 1123
  • [9] Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy
    Lee, Young Mok
    Jun, Hyun Sik
    Pan, Chi-Jiunn
    Lin, Su Ru
    Wilson, Lane H.
    Mansfield, Brian C.
    Chou, Janice Y.
    HEPATOLOGY, 2012, 56 (05) : 1719 - 1729
  • [10] Development of Strategy for Multi-Dose Gene Therapy in Murine Model of Glycogen Storage Disease Type Ia
    Arends, Charles
    Ameen, Yasir
    Lee, Young Mok
    MOLECULAR THERAPY, 2023, 31 (04) : 571 - 572
12345